(Total Views: 289)
Posted On: 01/28/2022 2:08:21 PM
Post# of 1418
Stories continue to pop-up. I like this one as it's very easy to read and understand for anyone that hasn't been following Todos or understands trials.
January 28, 2022 - Todos Medical, NLC Pharma reveal positive Phase II hospitalised Covid-19 trial data
In the trial's Part 2, 0% Covid-19 deaths were observed with Tollovir versus 22% in the placebo arm.
https://www.clinicaltrialsarena.com/news/todo...vid-trial/
Notice this as the end...
"Tollovir is an oral antiviral inhibitor of 3CL protease. It is also an anti-cytokine therapy candidate to treat nidovirus subcategory of coronaviruses comprising SARS-CoV-2, Covid-19, SARS-CoV-1, MERS and 229E. "
BTW:
There is no approved treatment specifically for MERS
Currently no medicine is available to cure MERS
Approximately 35% of patients with MERS-CoV have died.
It will be interesting to see how Tollovid helps other viruses and issues beyond Covid-19
Oh and I looked up Clinicaltrialsarena.com
"Clinicaltrialsarena.com is one of a network of 30+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year ."
January 28, 2022 - Todos Medical, NLC Pharma reveal positive Phase II hospitalised Covid-19 trial data
In the trial's Part 2, 0% Covid-19 deaths were observed with Tollovir versus 22% in the placebo arm.
https://www.clinicaltrialsarena.com/news/todo...vid-trial/
Notice this as the end...
"Tollovir is an oral antiviral inhibitor of 3CL protease. It is also an anti-cytokine therapy candidate to treat nidovirus subcategory of coronaviruses comprising SARS-CoV-2, Covid-19, SARS-CoV-1, MERS and 229E. "
BTW:
There is no approved treatment specifically for MERS
Currently no medicine is available to cure MERS
Approximately 35% of patients with MERS-CoV have died.
It will be interesting to see how Tollovid helps other viruses and issues beyond Covid-19
Oh and I looked up Clinicaltrialsarena.com
"Clinicaltrialsarena.com is one of a network of 30+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across the world with a combined readership of 55 million industry professionals each year ."
(1)
(0)
